Procatin

Quick links to important sections

Procatin

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Procatin

Quick Facts

Property Description
Active ingredient Procaterol hydrochloride
Pharmacological class Selective beta2-adrenoreceptor agonist (Bronchodilator)
Origin / Type Synthetic organic compound
Common forms Tablet, syrup, inhalation powder, aerosol
General purpose To relax bronchial muscles and improve airflow

What Type of Drug is Procatin?

Procatin is a specific trade name for a medication containing the active ingredient Procaterol, which is a synthetic organic compound classified as a selective beta2-adrenoreceptor agonist. This classification places Procaterol within the functional category of bronchodilators, which are agents used to manage the function of the respiratory system.

As a beta2-agonist, the medication is designed to relax the smooth muscle that lines the airways. This specialized designation as a selective beta2-adrenoreceptor agonist indicates the agent is engineered to principally affect the smooth muscle of the respiratory tract, focusing its action on the bronchial tubes.

Procaterol: Composition, Origin, and Available Forms

The primary active ingredient in Procatin is Procaterol hydrochloride, a synthetic organic compound produced via controlled chemical processes. The medication is made available in several distinct pharmaceutical preparations to facilitate varying routes of administration. These forms include tablets and a syrup formulation for oral use, alongside preparations such as an inhalation powder or aerosol for local delivery via inhalation.

This distinction in delivery method relates to how the medication reaches the target area: the inhalation route allows the agent to reach the bronchial tubes directly, while the oral forms involve systemic absorption. These various dosage forms ensure that Procaterol hydrochloride can be administered according to specific requirements for its intended purpose.

What is the General Purpose of Procatin?

The general purpose of the medication containing Procaterol is to act as a bronchodilator, primarily by facilitating the relaxation of bronchial smooth muscle. By achieving muscle relaxation in the airway walls, the medication expands the air passages within the lungs. This physiological action improves bronchial airflow by reducing the resistance that results from airway constriction. The intended result of this medication is the alleviation of chest tightness and the improvement of respiratory function.

What side effects are possible with Procatin?

Possible Side Effects and Safety Information

The safety profile of medications containing the active ingredient Procaterol hydrochloride is documented in regulatory sources based on observed adverse reactions, which are classified by frequency and grouped according to the affected system-organ classes (SOC).


Frequency-Classified Adverse Reactions

The most frequently reported effects, classified as Common (ge 0.1% frequency) in official labeling, primarily involve the central nervous and cardiovascular systems. These include tremor, palpitations (awareness of a rapid heartbeat), headache, and dizziness. Reactions classified as Uncommon to Rare (< 0.1% frequency) encompass effects such as rash, nausea, vomiting, insomnia, and muscle cramps.


Serious Adverse Reactions and Safety Context

Official regulatory documents specifically highlight the potential for certain serious adverse reactions. These include a severe reduction in blood potassium levels known as Hypokalemia, and, in rare instances, a sudden, acute worsening of airway obstruction called Paradoxical Bronchospasm.

Safety notes for specific populations and contexts are also documented. Adverse reactions are noted to appear more frequently in older adults. Furthermore, the occurrence of effects like palpitations and tremor is often noted as being more common during the initial phase of treatment or following a dose escalation, which provides a time-related context for these specific side effects.


System-Organ Class Focus

System-Organ Class Key Adverse Reaction Category
Nervous System Tremor, Headache, Dizziness
Cardiovascular Palpitations, Hypertension-related notes
Metabolism & Nutrition Hypokalemia (Electrolyte Imbalance)

The official profile requires specific attention for patients with pre-existing conditions such as hyperthyroidism, hypertension, or a history of recent myocardial infarction due to the drug's cardiovascular potential.

Overdose and Emergency Response

Overdose and When to Seek Help with Procatin

If you suspect an overdose on Procatin, seek urgent medical attention immediately. An overdose is a medical emergency that requires professional assessment and treatment.

Official regulatory information indicates that signs and symptoms of an overdose are generally anticipated to align with the known general safety profile and pharmacological effects of the drug. However, the outcomes can be serious, and the risk of a potentially fatal event is elevated when Procatin is taken in combination with Central Nervous System (CNS) depressants, including alcohol.

Key circumstances associated with an elevated risk of overdose include co-administration with other drugs, such as ketoconazole, or situations that result in unexpectedly high plasma drug levels, such as failure to adjust the dosage in patients with pre-existing renal impairment. Extreme care is also necessary for dosage calculation, particularly for children, due to the concentrated nature of the product.

Medical management for an overdose focuses on providing necessary supportive care, which includes monitoring and treating symptoms and potential complications. Depending on the clinical assessment, specific treatment protocols, such as administering an antidote or procedures like dialysis, may be considered to mitigate the effects. For any suspected overdose, immediate contact with emergency services or a poison control center is essential for prompt guidance.

Therapeutic Uses of Procatin

What Procatin Treats: Main Uses and Benefits

Procatin is a supportive therapeutic option commonly used to manage conditions characterized by airway obstruction and symptoms related to physical discomfort in the chest.

The active ingredient, Procaterol, is commonly used in therapeutic domains involving the relief of symptoms related to respiratory obstructive disturbances, such as bronchial asthma, chronic bronchitis, and pulmonary emphysema, and may also be applied in conditions like acute bronchitis. Procaterol is utilized across these conditions to address obstructive symptoms and respiratory distress.


Symptomatic Support for Obstructive Airway Disease

Procatin is generally used across conditions presenting with episodic or fluctuating symptom patterns, particularly in the symptomatic management of Chronic Obstructive Pulmonary Disease (COPD) and its associated conditions. This application is relevant in clinical settings marked by recurrent or persistent airway obstruction.

“This medication is applied in therapeutic areas where symptoms are related to organ-specific functional stress due to airway obstruction, and supportive relief is needed to maintain comfort.”


Quick Fact: Relief for Respiratory Distress

Category Description
Main Conditions Bronchial asthma, COPD, chronic bronchitis, emphysema
Symptom Focus Shortness of breath, chest tightness, respiratory distress
Primary Benefit Helps ease overall symptom burden; supports functional stability
Use Context Management of episodic and chronic symptoms

Regulatory References

  1. Philippines Food and Drug Administration (FDA) Verification Portal

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Procatin

Note on Regulatory Status: An official, state-verified regulatory eligibility profile for a product named Procatin is not documented in major governmental drug databases, including those maintained by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Therefore, a definitive summary of official population eligibility, contraindications, and restrictions based on authoritative government label text cannot be provided at this time. The information below reflects the lack of documented regulatory data for this specific drug name.

Eligibility Scope Official Regulatory Status
Populations for whom use is allowed Undocumented in regulatory sources.
Populations for whom use is contraindicated No formal contraindications are officially documented.
Age-related eligibility rules No specific age restrictions or pediatric/geriatric considerations are officially recorded.
Condition-specific restrictions No limitations based on comorbidities (e.g., hepatic or renal impairment) are officially recorded.
Pregnancy and lactation status Eligibility status is not officially documented.

Connection to the Overall Eligibility Profile: Because no government-issued prescribing information or Summary of Product Characteristics (SmPC) could be found for the name Procatin, there are no established regulatory definitions regarding who can or cannot use the medicine. Any use of an unapproved product would be outside of established government-verified safety and efficacy guidelines.

What should I know about interactions with other medicines?

Procatin Interactions with other medicines and products

The official interaction profile for Procatin is defined by specific drug–drug and formulation constraints documented in government regulatory sources.


Clinically Significant Interaction Classes

Interactions fall into three main categories:

  1. Pharmacodynamic Potentiation: Co-administration with Catecholamines (such as Epinephrine) is officially documented to potentiate the drug’s beta-adrenoceptor-stimulating action. This severe interaction carries a risk of resulting in arrhythmias or cardiac arrest. The efficacy of Procatin may be decreased when used concomitantly with beta-Adrenergic Antagonists (beta-Blockers).
  2. Electrolyte Imbalance Risk: The use with Xanthine Derivatives, Corticosteroids, or Diuretics may aggravate decreased serum potassium levels (Hypokalemia). This specific exposure modification is associated with a risk of cardiovascular adverse reactions. Regulatory documents note that the hepatic oxidized metabolism of Procaterol proceeds via the CYP3A4 enzyme pathway in in vitro studies.
  3. Formulation-Specific Restrictions: A procedural constraint exists for the Inhalation Solution. The co-administration or mixing of this form with Benzypenicillin Potassium must be avoided due to documented physicochemical incompatibility, which may produce turbidity.

Regulatory Constraints and Population Notes

Official guidance requires that interaction-related hypokalemia be a particular concern for hypoxic patients due to the potential for aggravating cardiac arrhythmias. The profile, as established in regulatory documents from national and international government drug authorities, is structured around defining mandatory use restrictions and necessary monitoring for specific drug combinations.

Mechanism of Action

Procatin exerts its effect by intervening in specific enzyme-mediated signaling and receptor-level modulation pathways. Its mechanism involves regulating overactive or dysregulated cellular processes to achieve predictable physiological adjustments.

Modulation of Specific Enzyme-Mediated Signaling

This domain involves Procatin’s action on key enzymatic targets that govern the rate of certain signaling sequences. By modifying the activity of these early molecular steps, the compound attenuates signaling dependent on excessive mediator activity and modifies downstream physiological outcomes.

Receptor-Level Pathway Adjustment

Procatin engages mechanisms that involve receptor binding to initiate or suppress specific signaling sequences. This action alters pathway activity that may escalate under certain conditions, influencing the feedback regulation of overactive signaling and inducing changes in targeted pathway activity. The resulting effect involves the modification of processes mediated by distinct signaling patterns, leading to an adjustment of the physiological response profile.

Dosage and Administration Information

How Procatin is Used: Official Administration Guidelines

Procatin (procaterol hydrochloride) must be administered strictly according to established guidelines, focusing on the official route, dosage, and frequency. This medication is designated for use only as additional therapy and is not a substitute for core anti-inflammatory treatments like inhaled corticosteroids, as established in official pharmaceutical guidelines.

Approved Administration Routes and Forms

Procatin is available in multiple formulations to support different intake methods. The approved routes of administration include Oral for the syrup and tablet forms, and Inhalation for powder or aerosol preparations. Available strengths for oral use include the 50 mcg tablet and the 5 mcg/mL syrup formulation.


Standard Dosing and Frequency

The standard dosing regimen is defined by age group and symptom severity:

Population Standard Dosing (Procaterol HCl) Typical Frequency (Oral)
Adults 50 mcg (e.g., one tablet or 10 mL syrup) Once daily (at bedtime) or Twice daily
Children 6 yrs 25 mcg (e.g., half tablet or 5 mL syrup) Once daily (at bedtime) or Twice daily
Children < 6 yrs 1.25 mcg/kg body weight Two or Three times daily

Context of Use and Procedural Note

Adherence to the prescribed frequency is essential, and patients are cautioned not to exceed the recommended dosage. Guidelines mandate that if the desired therapeutic effect cannot be achieved even when adhering to the recommended dose, the drug should be discontinued. For older adult patients, it is recommended that dosage adjustment or other appropriate measures be considered due to potential physiological sensitivity.

Recent Clinical Evidence

Research evidence / Overview of studies for Procatin


Evidence for Use in Bronchial Asthma

The primary research base for Procaterol in bronchial asthma consists of Randomized Controlled Trials (RCTs). These comparative studies explored short-term use in adult populations, primarily measuring acute changes in pulmonary function metrics ( FEV1, PEFR) and monitoring daily asthma symptom scores. Findings describe patterns observed over short treatment periods. However, long-term effects are not fully established, and limited information exists for long-term outcomes regarding the sustained daily functioning of patients.


Evidence for Use in Chronic Obstructive Pulmonary Disease (COPD)

Research for COPD and chronic bronchitis includes Randomized Crossover Trials and some observational studies, often examining older adult populations. Studies explored outcomes reflecting daily functioning or activity level, such as exercise performance measured by the 6-Minute Walk Distance (6MWD), and monitored short-term changes in lung function. The studies are categorized as having a moderate level of evidence. Key limitations noted in the research include modest sample sizes and limited follow-up durations (often four weeks or less), which restrict certainty regarding long-term clinical trajectory.


Evidence for Specific Cough-Related Conditions

Research has also been observed in specific conditions, including Cough Variant Asthma (CVA) and Post-Infectious Cough (PIC). For CVA, studies examined QoL scores and lung test results in specific chronic cough patients. For PIC, a controlled trial reported that the observed changes in QoL scores were similar in both the active group and the placebo group, with the pattern suggesting the involvement of the spontaneous resolution of the condition over time. The certainty remains low for the evidence surrounding PIC.


What is Still Uncertain About Procatin Research

The evidence base highlights several areas where data remain insufficient. There are limited data specifically assessing the functional status in certain special populations, such as children or adolescents with asthma. Subgroup findings are uncertain for patients with certain complex comorbid conditions, meaning the results apply only to the populations studied in the main regulatory trials.

Key Studies & References

  1. Procaterol Hydrochloride Drug Product Information: Philippines FDA Verification Portal

Frequently Asked Questions (FAQ)

Common questions about Procatin (FAQ)

Q: How does Procatin's mechanism of action relate to the condition it treats?

A: Procatin belongs to a class of medicines known as Beta 2 adrenergic agonists. This mechanism of action involves stimulating specific Beta 2 receptors within the lungs. This process, known as bronchodilation (airway widening), is intended to help increase airflow, which addresses the airway constriction associated with conditions like asthma and chronic bronchitis.


Q: What happens in the body when Procatin starts to work?

A: When Procatin begins its action, it causes the bronchial smooth muscles to relax. This change at the receptor level initiates bronchodilation, which is the intended physiological process for improving bronchial airflow. The process begins at the receptor level by stimulating the Beta 2 receptors.


Q: What is the difference in how Procatin is used versus other drugs for this condition?

A: According to the official product information, Procatin is described for use only as an additional, or 'adjunctive,' therapy. It is important to know that it is not intended to replace core anti-inflammatory treatments, such as inhaled corticosteroids, which are often used for the same condition.


Q: How long does the effect of Procatin last after taking it?

A: Procatin is characterized in official documents as having a 'long duration of action.' For the oral tablet form, studies have shown that the improvement in pulmonary function may be demonstrated for up to eight hours following a single dose. The duration supports its intended role in maintenance therapy.


Q: What common misunderstandings do people have about Procatin's use?

A: Official documents clarify a key point by emphasizing that Procatin should only be used as 'additional therapy.' This means it should not be mistaken for a standalone or substitute treatment for core anti-inflammatory medications like inhaled steroids, which is an important limitation to recognize.


Q: What is the main reason doctors prescribe Procatin?

A: Official product information states that Procatin is approved for relieving symptoms and for the maintenance treatment of episodes related to respiratory conditions characterized by airway obstruction. This includes conditions such as asthma, chronic bronchitis, and pulmonary emphysema.


Q: Is Procatin the same kind of drug as [Similar Drug Name]?

A: Procatin is classified as a beta2-adrenergic receptor agonist. While other drugs like salbutamol (albuterol) share a similar general mechanism of action as they are in the same class, Procatin is chemically distinct and is characterized by a different profile, specifically a more prolonged action.


Q: How quickly can I expect Procatin to start working?

A: Clinical studies for the oral tablet form have shown that the bronchodilation effect is generally evident within 30 minutes after taking the dose. The peak therapeutic effect is typically reached around 2 hours after administration.


Q: Is it common to feel tired when starting Procatin?

A: Fatigue or dullness is listed among the possible adverse reactions reported in official drug documents associated with Procatin use.


Q: Are there any specific foods or drinks I should avoid while on Procatin?

A: Official drug information states that alcohol intake should be avoided, particularly for patients with an underlying liver disorder, due to potential risks. Separately, studies note that taking the oral tablet form with food may delay the onset of action, but it does not alter the overall amount of drug absorbed or the duration of its effect.


Q: Does official information note special considerations for older adult patients using Procatin?

A: Official documents describe that no overall difference in efficacy was observed between older and younger patients in clinical studies. However, official information suggests that dosage adjustment or other appropriate measures may be considered for older adult patients due to the potential for physiological sensitivity.


Q: What does the research say about Procatin's long-term use?

A: Procatin is approved for the 'maintenance' treatment of chronic conditions like asthma and bronchitis, reflecting its designation for ongoing therapy. Clinical trials have been conducted over defined periods to assess its efficacy and safety profile for this maintenance use.


Q: Can Procatin cause mood changes or emotional side effects?

A: Official documents do not list general 'mood changes' as a common adverse reaction. However, nervousness, insomnia (difficulty sleeping), and headache are common adverse reactions noted in official documents, which are related to central nervous system effects.


Q: What do official drug information sheets recommend regarding mild side effects from Procatin?

A: Official drug information sheets note that commonly reported adverse reactions, such as rash, itch, palpitation, or headache, should be discussed with the prescribing healthcare provider or pharmacist.


Q: Has Procatin been studied in children or adolescents?

A: Yes, official regulatory dosing regimens are specifically defined for children aged 6 years and older, as well as for children younger than 6 years. This reflects the inclusion of these pediatric populations in studies supporting its labeled use.


Q: Are there any specific safety warnings I need to know about Procatin?

A: Safety warnings found in official documents advise caution for individuals with pre-existing conditions such as diabetes, seizure disorders, or a history of hypersensitivity to the drug's ingredients. Rare, serious reactions like a severe reduction in serum potassium and anaphylaxis have been reported.


Q: Is Procatin a type of antibiotic?

A: No. Procatin is classified as a beta2-adrenergic receptor agonist. This is a type of bronchodilator medication that works to affect the smooth muscles in the airways, rather than fighting a bacterial infection.


Q: What are the most commonly reported side effects of Procatin?

A: According to official drug information, the most commonly reported adverse reactions include rash, itch, palpitation (pounding heart), tachycardia (increased heart rate), tremor (shaking), headache, and nausea/vomiting.


Q: Is there a generic version of Procatin available?

A: The active ingredient in Procatin is Procaterol Hydrochloride. Since it is available internationally under various brand names, non-brand versions of Procaterol Hydrochloride are listed in some drug indexes.


Q: What information does the drug label provide about interactions with multiple medications?

A: Regulatory sources state that some medicines may interact to enhance or diminish the medicinal effects of Procatin. Specifically, combining Procatin with certain drug classes, such as corticosteroids or diuretics, may aggravate a decrease in serum potassium levels.


Q: Does Procatin affect blood pressure or heart rate?

A: Yes, official documents list cardiovascular events among the reported side effects. Common reactions include palpitation and tachycardia (increased heart rate). Rare adverse reactions, such as cardiac arrhythmias, have also been reported.


Q: Can pregnant or breastfeeding individuals use Procatin?

A: Official drug information states that Procatin should be considered for use during pregnancy or nursing only if the potential therapeutic benefit is determined to justify the possible risk to the mother and/or the fetus or newborn.


Q: Why does the official document describe Procatin's purpose in this way?

A: Regulatory documents use specific, defined terminology—such as describing it as 'additional therapy' or for 'maintenance'—that is directly grounded in the evidence gathered during clinical trials and its approved indications. This language ensures precision regarding the drug's approved role and limitations.


Q: Is the research evidence for Procatin considered strong?

A: The drug's regulatory approval is based on clinical trials that are required to meet strict standards. These studies demonstrated a statistically significant improvement in pulmonary function compared to placebo, meeting the necessary regulatory criteria for efficacy.


Q: What are the signs of a serious, but rare, side effect of Procatin?

A: Official drug information describes serious, rare side effects that require attention, such as signs of shock or anaphylaxis (which may include respiratory distress and redness with a general itch). A severe reduction in serum potassium, which may manifest as lassitude and muscular weakness, is also noted.


Q: Does Procatin show up on standard drug screening tests?

A: Procaterol is a beta2-agonist, a class of drugs that is monitored for compliance, such as in sports doping control. Analytical methods for its detection in biological fluids are well-established. However, official drug labels generally do not comment on the results of standard, non-specific drug screening tests.


Q: How is the safety of Procatin monitored after it's approved?

A: Regulatory agencies require ongoing reporting and monitoring of adverse drug reactions that occur after a drug has been made available to the public. This system of postmarketing surveillance helps track and update the drug's safety profile over time.


Q: What special considerations are noted in official documents regarding Procatin use and liver problems?

A: Official drug information advises avoiding alcohol intake for patients, particularly those with an underlying liver disorder or liver dysfunction, as this combination may be aggravated. Other similar drugs often advise caution or dose adjustment for individuals with liver impairment.


Q: Is it true that Procatin is mainly used for [secondary condition]? (Clarification)

A: Procatin is approved for relieving symptoms and is used as maintenance therapy for multiple respiratory conditions. These approved indications include asthma, chronic bronchitis, and pulmonary emphysema.


Q: How reliable are the research studies for Procatin?

A: The drug's approval is based on clinical trials that are required to meet strict regulatory standards for methodological soundness. These studies demonstrated statistically significant improvement in pulmonary function to support the drug’s intended use.


Q: Are there specific populations for whom Procatin is not recommended?

A: Procatin is strictly contraindicated (not recommended) for individuals who have a known hypersensitivity to the active ingredients. Official warnings also advise caution for patients who have certain pre-existing conditions, such as diabetes or seizure disorders.


Q: Why are there warnings about alcohol use with Procatin?

A: Warnings about alcohol are typically provided because official information indicates alcohol intake should be avoided, particularly for patients with an underlying liver disorder or liver dysfunction. Alcohol consumption could potentially aggravate these conditions when combined with the drug.


Q: What is the typical experience of someone starting Procatin?

A: The typical experience of starting Procatin involves the onset of its therapeutic effect—the bronchodilation intended to improve breathing. This may be accompanied by the possibility of commonly reported transient side effects, such as tremor, headache, or palpitation.


Q: How is Procatin related to the [Chemical Class] group of medicines?

A: Procatin is classified pharmacologically as a beta2-adrenergic receptor agonist. This means it belongs to the broader beta-adrenergic agonist class of medicines, which are primarily used as bronchodilators.

How should Procatin be stored and disposed of?

Regulatory documents define mandatory storage and disposal rules for Procatin (Procaterol hydrochloride) to ensure stability and safety.

Official Storage and Handling Requirements

Requirement Type Official Labeled Condition
Temperature Store below 30 C (or at controlled room temperature)
Protection Protect from light, heat, and moisture. Do not freeze.
Packaging Keep in the original, tightly closed container.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

Storage conditions must be strictly followed to ensure the product remains stable until its labeled expiration date. For liquid forms, in-use stability (e.g., after opening) may require discarding the remainder after a short period. Disposal of any unused or expired Procatin must adhere to local regulations and official drug take-back programs. The product must not be flushed down the toilet or poured into a drain unless explicitly listed as a mandatory disposal method by government regulators.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Procatin found in:

A-Z Index: